Hirotaka Watada

Has grant

Professor

Juntendo University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hirotaka Watada is a Professor at Juntendo University in Japan, specializing in diabetes management and clinical immunodiabetes. His recent research includes the clinical use of once-weekly insulin Icodec and the exploration of new biomarkers for Type 1 diabetes. Additionally, his work examines the relationship between carbohydrate intake and cardiovascular events in individuals with Type 2 diabetes. Professor Watada's contributions significantly advance understanding of diabetes treatment and management strategies.

Recent Grants

Grant: Close

Autophagic failure in islets

Open Date: 2017-04-01

Close Date: 2020-03-31

Grant: Close

膵α細胞特異的オートファジー不全マウスの作製とその機能解析

Open Date: 2017-04-01

Close Date: 2020-03-31

Grant: Close

膵β細胞特異的・時期誘導性オートファジー不全モデルマウスの作製とその機能解析

Open Date: 2017-04-01

Close Date: 2020-03-31

Grant: Close

糖尿病の病態解明に向けた膵α細胞新生・成熟機構の解明

Open Date: 2016-04-01

Close Date: 2018-03-31

Grant: Close

Autophagic failure of smooth muscle cells

Open Date: 2016-04-01

Close Date: 2018-03-31

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Yoshio Fujitani

Professor

JAPAN

View details

Yoshifumi Tamura

JAPAN

View details

Hiroaki Satoh

Professor

Juntendo University Hospital

JAPAN

View details

Yuya Nishida

Associate Professor

Juntendo University

JAPAN

View details

Jun Wada

Professor

Okayama University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hirotaka Watada

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (21)

Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management

A Possible New Biomarker for T1D? : RNA Splicing in Circulating Blood

The Beck Depression Inventory‐II scores of adults with type 1 diabetes in Japan: Analysis using the Juntendo‐Aso Type 1 Diabetes (JAT‐1) Cohort

The Arrival of the Era of Clinical Immunodiabetes

Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post‐hoc analysis of imeglimin clinical trial data

Relationship of Carbohydrate Intake Proportion to Cardiovascular Events in Japanese People With Type 2 Diabetes Mellitus

Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus

One step closer to solving the mystery of the anti‐inflammatory effects of glucagon‐like peptide‐1 receptor agonists

Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data‐driven cluster analysis: A post‐hoc analysis of imeglimin clinical trial data

Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus

Efficacy and safety of once‐weekly insulin icodec versus once‐daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials

Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of two randomized, placebo‐controlled trials

Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta‐analysis of randomized controlled trials

Diabetic ketoacidosis due to a sensor defect of FreeStyle Libre: A case report

A 7 day inpatient diabetes education program improves quality of life and glycemic control 12 months after discharge

Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial

Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study

Cover Image, Volume 24, Issue 12

Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan

Establishment of an enzyme-linked immunosorbent assay for mouse pancreatic polypeptide clarifies the regulatory mechanism of its secretion from pancreatic γ cells

Efficacy and safety of imeglimin add‐on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double‐blind, placebo‐controlled phase 3 trial with a 36‐week open‐label extension period

Collaborators (5)

Yoshio Fujitani

Yoshifumi Tamura

Hiroaki Satoh

Yuya Nishida

Jun Wada

Make your next move.